10.54
price up icon1.15%   0.12
after-market Dopo l'orario di chiusura: 10.75 0.21 +1.99%
loading
Precedente Chiudi:
$10.42
Aprire:
$10.5
Volume 24 ore:
749.31K
Relative Volume:
0.96
Capitalizzazione di mercato:
$725.27M
Reddito:
$46.02M
Utile/perdita netta:
$-70.80M
Rapporto P/E:
-5.7912
EPS:
-1.82
Flusso di cassa netto:
$-1.61M
1 W Prestazione:
+3.64%
1M Prestazione:
+25.18%
6M Prestazione:
+38.14%
1 anno Prestazione:
+19.77%
Intervallo 1D:
Value
$10.48
$11.08
Intervallo di 1 settimana:
Value
$9.695
$11.08
Portata 52W:
Value
$3.91
$13.98

Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile

Name
Nome
Eyepoint Pharmaceuticals Inc
Name
Telefono
617-926-5000
Name
Indirizzo
480 PLEASANT STREET, WATERTOWN, MA
Name
Dipendente
144
Name
Cinguettio
@eyepointpharma
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
EYPT's Discussions on Twitter

Confronta EYPT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
EYPT
Eyepoint Pharmaceuticals Inc
10.54 699.82M 46.02M -70.80M -1.61M -1.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-17 Iniziato RBC Capital Mkts Outperform
2025-01-07 Iniziato Citigroup Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-08-28 Iniziato Jefferies Buy
2024-01-22 Iniziato JP Morgan Overweight
2023-11-02 Iniziato Mizuho Buy
2023-04-21 Iniziato Robert W. Baird Outperform
2022-07-07 Iniziato Chardan Capital Markets Buy
2021-03-01 Iniziato Cowen Outperform
2021-01-28 Iniziato Cantor Fitzgerald Overweight
2020-04-06 Downgrade B. Riley FBR Buy → Neutral
2019-11-04 Ripresa Laidlaw Buy
2019-09-12 Iniziato Guggenheim Buy
Mostra tutto

Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie

pulisher
Jul 21, 2025

Is EyePoint Pharmaceuticals Inc. a good long term investmentFastest-growing stock picks - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about EyePoint Pharmaceuticals Inc. stockExplosive capital gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

EyePoint Pharmaceuticals Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

What drives EyePoint Pharmaceuticals Inc. stock priceHigh-margin investment plays - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 563 - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Jul 16, 2025
pulisher
Jul 16, 2025

EyePoint Pharmaceuticals Awards 63,900 Shares in Employee Stock Options Under NASDAQ Rule - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

EyePoint Pharmaceuticals Acquisition by Federated Hermes Highlights Interest in Healthcare Sector - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

What makes EyePoint Pharmaceuticals Inc. stock price move sharplyFree Insider Trading Tips - beatles.ru

Jul 15, 2025
pulisher
Jul 14, 2025

Pleasing Signs As A Number Of Insiders Buy EyePoint Pharmaceuticals Stock - simplywall.st

Jul 14, 2025
pulisher
Jul 09, 2025

EyePoint Pharmaceuticals (EYPT) Soars 10.15% on Clinical Trial Progress - AInvest

Jul 09, 2025
pulisher
Jul 05, 2025

Trend Tracker for (EYPT) - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jun 30, 2025

EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 20, 2025

EyePoint Pharmaceuticals Approves Share Increase at Annual Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates Coverage on EyePoint Pharmaceuticals (EYPT - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

EyePoint Pharmaceuticals (EYPT) Poised for Success with Positive Outlook | EYPT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates EyePoint Pharmaceuticals at Outperform With $28 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

After Leaping 47% EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar - simplywall.st

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint (EYPT) Grants Stock Options to New Employees as Inducement | EYPT Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Awards 12,500 Shares in Stock Options to Three New Hires at $9.03 Per Share - Stock Titan

Jun 16, 2025
pulisher
Jun 14, 2025

(EYPT) Trading Report - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 12, 2025

EyePoint Stock: Retaining My 'Risky Buy' CallPivotal Data Due Early 2026 (NASDAQ:EYPT) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on EYPT FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

EyePoint at Goldman Sachs Healthcare Conference: Sustained-Release Vision By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 09, 2025

Breakout Momentum Plays You May Not Know About - Investing.com

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Has $302,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Ameriprise Financial Inc. Grows Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Raises Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Cookies Notice - EyePoint Pharmaceuticals

Jun 03, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 8,981 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

(EYPT) Investment Report - news.stocktradersdaily.com

Jun 01, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Eyepoint projects DURAVYU Phase 3 enrollment completion by H2 2025 amid strong clinical trial momentum - MSN

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Buys New Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 31, 2025
pulisher
May 30, 2025

EyePoint advances with Duravyu Phase III trial - Yahoo

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on EyePoint with $22 target - Investing.com India

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on EyePoint with $22 target By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholders are up 29% this past week, but still in the red over the last year - simplywall.st

May 30, 2025
pulisher
May 30, 2025

EyePoint Pharmaceuticals’ (EYPT) Buy Rating Reaffirmed at HC Wainwright - Defense World

May 30, 2025
pulisher
May 29, 2025

Biggest Companies on Nasdaq EyePoint Pharmaceuticals Insights by Kalkine - Kalkine Media

May 29, 2025
pulisher
May 29, 2025

Analyst Expectations For EyePoint Pharmaceuticals's Future - Benzinga

May 29, 2025
pulisher
May 29, 2025

EyePoint Pharmaceuticals (EYPT) Reiterates Buy Rating with $22 P - GuruFocus

May 29, 2025

Eyepoint Pharmaceuticals Inc Azioni (EYPT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):